MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0217626
Tradex Pharma Private Limited
Tradex Pharma Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹31.28 Cr
▲ 174% YoY
Net profit · FY 2025
₹42.9 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹59.68 Lakh
EBITDA margin 1.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹5.06 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Tradex Pharma Private Limited
Data last updated:
Tradex Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24110RJ2021PTC073094.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors Nikhil Agarwal and Vinod Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.28 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹42.9 Lakh (net margin 1.4%) and EBITDA of ₹59.68 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 71% over three years.
As per MCA filings, the company has open charges of ₹5.06 Cr on record.
Tradex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0217626).
Company details
CIN U24110RJ2021PTC073094
Registration Number 073094
Incorporation Date 21 January 2021
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-RJ-17-0217626
Key People
Nikhil Agarwal Director Vinod Kumar Director Recognitions & Rankings of Tradex Pharma
Contact details
Tradex Pharma Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. B – 123, Vkia Road No. 9A, Jaipur, Rajasthan, India – 302013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tradex Pharma Private Limited, buy the company report.
Comprehensive company report
Tradex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Tradex Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tradex Pharma Private Limited, buy the company report.
Financials of Tradex Pharma Private Limited
FY 2025 filings availableTradex Pharma Private Limited reported revenue of ₹31.28 Cr (up 174% YoY) for FY 2025.
Revenue · FY 2025
₹31.28 Cr ▲ 174%
Net profit · FY 2025
₹42.9 Lakh margin 1.4%
EBITDA · FY 2025
₹59.68 Lakh margin 1.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 174%
3 years · compounded
▲ 71%
EBITDA CAGR growth
1 year
▲ 208%
3 years · compounded
▲ 135%
Revenue has grown at a compounded annual rate (CAGR) of 71% over three years, including 174% growth in the latest year. EBITDA rose 208% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tradex Pharma Private Limited, buy the company report.
Board of directors of Tradex Pharma Private Limited
Tradex Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Agarwal Also directs: Grova Pharma LLP, Neoventis Medicare Private Limited | Director | 21 Jan 2021 | 5 Years 9 Months | Current |
| Vinod Kumar Also directs: Neoventis Medicare Private Limited | Director | 21 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Tradex Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arc Fintube Technologies Private Limited | ₹31.3 Cr (FY 2025) | 20.0% | Mumbai, Maharashtra, India | |||
| Hanuman Agro Industries Private Limited | ₹31.3 Cr (FY 2025) | -22.0% | Delhi, India | |||
| Aashapurna Texoprint Private Limited | ₹31.3 Cr (FY 2025) | -1.0% | Kolkata, West Bengal, India | |||
| Rekwell Trademart Private Limited | ₹31.29 Cr (FY 2022) | 1216.0% | Daulatpur, Delhi, India | |||
| Ciba Masala Udyog Private Limited | ₹31.28 Cr (FY 2024) | 17.0% | Alwar, Rajasthan, India | |||
| Tradex Pharma Private Limitedthis company | ₹31.28 Cr (FY 2025) | ₹42.9 Lakh | 1.4% | 174.0% | Jaipur, Rajasthan, India | |
| Shreenathji Luxury Impex Private Limited | ₹31.28 Cr (FY 2025) | 30.0% | Mumbai, Maharashtra, India | |||
| Pharmaceutical Institute of India Private Limited | ₹31.28 Cr (FY 2025) | 74.0% | Cuttack, Odisha, India | |||
| Saurashtra Cotton and Agro Products Private Limited | ₹31.27 Cr (FY 2025) | -50.0% | Rajkot, Gujarat, India | |||
| Oom Shanti Buildtrade Private Limited | ₹31.27 Cr (FY 2024) | 322.0% | Chakia, Bihar, India | |||
| Salamander Window & Door Systems Private Limited | ₹31.26 Cr (FY 2025) | -5.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Tradex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.06 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2025 | 101093270 | Others | ₹5 Cr | Open | |
| 27 Jan 2025 | 101066849 | Hdfc Bank Limited | ₹6.59 Lakh | Open |
To see the full charge records of Tradex Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Tradex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tradex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tradex Pharma Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Tradex Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tradex Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Nikhil Agarwal was appointed as Director on 21 Jan 2021.
Charges
A charge with Others of Rs. 499.90 Lakh registered on 28 Apr 2025 with Charge ID 101093270 was modified on 28 Nov 2025.
AGM
Tradex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 499.90 Lakh with Charge ID 101093270 was registered on 28 Apr 2025.
Filing
Tradex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 6.59 Lakh with Charge ID 101066849 was registered on 27 Jan 2025.
Appointed
Nikhil Agarwal was appointed as Director.
Appointed
Vinod Kumar was appointed as Director.
Incorporation
21 Jan 2021
Tradex Pharma Private Limited was registered on 21 Jan 2021 with Roc Jaipur & aged 5 years 9 months as per MCA records.
Frequently asked questions
Tradex Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 January 2021 (5+ years old) and is registered under CIN U24110RJ2021PTC073094.
Tradex Pharma has 2 current directors:
- Nikhil Agarwal - Director
- Vinod Kumar - Director
The latest financial statements of Tradex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Tradex Pharma is U24110RJ2021PTC073094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tradex Pharma was incorporated on 21 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Tradex Pharma by revenue are Arc Fintube Technologies Private Limited, Hanuman Agro Industries Private Limited, Aashapurna Texoprint Private Limited, Rekwell Trademart Private Limited, Ciba Masala Udyog Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Nikhil Agarwal was appointed as Director on 21 Jan 2021. Vinod Kumar was appointed as Director on 21 Jan 2021.
Yes, Tradex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-17-0217626).
The registered office of Tradex Pharma is at Plot No. B – 123, Vkia Road No. 9A, Jaipur, Rajasthan, India – 302013.
Tradex Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Tradex Pharma has open charges of ₹5.06 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages